Greater symptom duration predicts response to immunomodulatory therapy in dilated cardiomyopathy

International Journal of Cardiology

Volumn 128, Issue 1, 2008, Pages 38-41

  Stanton, Christopher ^a   Mookadam, Farouk ^a   Cha, Stephen ^a   McNamara, Dennis ^b   Aukrust, Pål ^c   Wojnicz, Romwald ^d   Bailey, Kent R ^a   Cooper, Leslie T ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Dilated cardiomyopathy; Heart failure; Immunoglobulin; Immunosuppression

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; PLACEBO; PREDNISONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG DOSE REDUCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMMUNOMODULATORY THERAPY; IMMUNOSUPPRESSIVE TREATMENT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; WILCOXON SIGNED RANKS TEST;

CARDIOMYOPATHY, DILATED; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; LOGISTIC MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STATISTICS, NONPARAMETRIC; STROKE VOLUME;

EID: 46149117759     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.05.016     Document Type: Article

References (19)

1. Felker G., Thompson R., Hare J., et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342 (2000) 1077-1084
2. Dec G.W., Palacios I.F., Fallon J.T., et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med 312 (1985) 885-890
3. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second Official Adult Heart Transplant Report-2005. J Heart Lung Transplant 24 (2005) 945-967
4. Pankuweit S., Portig I., Lottspeich F., and Maisch B. Autoantibodies in sera of patients with myocarditis: characterization of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis. J Mol Cell Cardiol 29 (1997) 77-84
5. Herskowitz A., Ahmed-Ansari A., Neumann D.A., et al. Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis. J Am Coll Cardiol 15 (1990) 624-632
6. Fuse K., Kodama M., Okura Y., et al. Short-term prognostic value of initial serum levels of interleukin-10 in patients with acute myocarditis. Eur J Heart Fail 7 (2005) 109-112
7. Fuse K., Kodama M., Okura Y., et al. Predictors of disease course in patients with acute myocarditis. Circulation 102 (2000) 2829-2835
8. Feldman A., and McNamara D. Myocarditis. N Engl J Med 343 (2000) 1388-1398
9. Mason J.W., O'Connell J.B., Herskowitz A., et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 333 (1995) 269-275
10. McNamara D.M., Holubkov R., Starling R.C., et al. Controlled trial of intravenous immune globulin in recent onset dilated cardiomyopathy. Circulation 103 (2001) 2254-2259
11. Parrillo J.E., Cunnion R.E., Epstein S.E., et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 321 (1989) 1061-1068
12. Wojnicz R., Nowalany-Kozielska E., Wojciechowska C., et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104 (2001) 39-45
13. Gullestad L., Aass H., Fjeld J.G., et al. Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure. Circulation 103 (2001) 220-225
14. Guyatt G.H., Cook D.H., Devereux P., Meade M., and Straus S. Therapy. In: Guyatt G.H., and Rennie D. (Eds). User's Guide to the Medical Literature: A Manual for Evidence-Based Clinical Practice (2002), AMA Press, Chicago (IL)
15. Garg A., Shiau J., and Guyatt G. The ineffectiveness of immunosuppressive therapy in lymphocytic myocarditis: an overview. Ann Intern Med 129 (1998) 317-322
16. Baughman K. Diagnosis of myocarditis: death of Dallas criteria. Circulation 113 (2006) 593-595
17. Hia C., Yip W., Tai B., and Quek S. Immunosuppressive therapy in acute myocarditis: an 18 year systematic review. Arch Dis Child 89 (2004) 580-584
18. Liu L., and Zhao S.P. The changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapy. Int J Cardiol 1 (1999) 77-82
19. Cleland J.G., Coletta A.P., and Clark A.L. Clinical trials update from the joint European Society and World Congress of Cardiology meeting: PEP-CHF, ACCLAIM and the HHH study. Eur J Heart Fail 8 (2006) 658-661